Search

everythinglearnresearchcommunity

for

Search:↓

The new visual scale is a quick and effective way to measure hair loss in women.

The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.

New treatment reduces hair shedding and increases hair density in women with early hair loss.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

1 mg/day of low-dose oral minoxidil is effective and safe for treating female hair loss.

Arab hair is generally thicker but less dense compared to other ethnicities, affecting hair disorder diagnosis and treatment.

Drinking a lot of sugary drinks may increase hair loss risk in young women.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

The document concludes that objective methods are important for diagnosing different types of alopecia and monitoring treatment, and standardizing these techniques is necessary.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Redheaded people have higher levels of a vitamin D precursor, suggesting red hair may be an adaptation for better vitamin D synthesis in areas with less sunlight.

Redheaded people may have evolved to efficiently make vitamin D in areas with less sunlight.

New understanding and treatments for hair loss are improving, but more research is needed.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

About 40% of women without hair loss and 60% with hair loss experience a lot of hair shedding, especially those under 50 with long hair.

A new topical solution safely reduces hair shedding by 38% on average by tightening a muscle in the scalp.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Minoxidil effectively treats female pattern hair loss.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.